Don’t miss the latest developments in business and finance.

Deplorable to overreact, entice fear without due diligence on vax: Vardhan

The health minister also referred to an earlier tweet by him on January 15, wherein he had posted a chart with details of all those people who should not get the vaccine Read more at: https://www.dec

Harsh Vardhan
Photo: PTI
Press Trust of India New Delhi
2 min read Last Updated : Jan 19 2021 | 10:28 PM IST

It is highly deplorable to overreact, entice fear and spread misinformation without doing any due diligence on COVID-19 vaccine, Union Health Minister Harsh Vardhan said on Tuesday after Bharat Biotech released a factsheet specifying conditions when Covaxin should not be given.

He was replying to a tweet that asked why such a crucial information was allegedly not made public earlier.

The health minister also referred to an earlier tweet by him on January 15, wherein he had posted a chart with details of all those people who should not get the vaccine.

"Highly deplorable to over-react, entice fear and spread misinformation without performing an iota of due diligence. These facts have been in public domain since the beginning. Follow @MoHFW_INDIA (health ministry Twitter handel) to stay informed and do some research before speaking out," Vardhan tweeted.

In the factsheet on COVID-19 vaccine Covaxin, Bharat Biotech has advised pregnant or breastfeeding women and people with high fever or bleeding disorders not to take the antidote.

The vaccine maker in the fact sheet on Covaxin, posted in its website, said the clinical efficacy of the vaccine is yet to be established and is being studied in phase three clinical trial, and hence it is important to appreciate that receiving the vaccine does not mean other precautions related to COVID-19 need not be followed.

Also Read

Covaxin has been granted approval for restricted use in emergency situations.

It is India's totally indigenous COVID-19 vaccine developed in collaboration with the Indian Council of Medical Research and the National Institute of Virology.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

More From This Section

Topics :Harsh VardhanCoronavirus VaccineBharat Biotech

First Published: Jan 19 2021 | 10:19 PM IST

Next Story